NBW Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$221K Buy
2,540
+153
+6% +$13K 0.05% 97
2025
Q1
$214K Buy
+2,387
New +$214K 0.05% 91
2024
Q4
Sell
-2,575
Closed -$232K 97
2024
Q3
$232K Buy
+2,575
New +$217K 0.04% 99
2024
Q2
Sell
-2,806
Closed -$245K 109
2024
Q1
$245K Sell
2,806
-5
-0.2% -$427 0.05% 93
2023
Q4
$232K Sell
2,811
-3
-0.1% -$229 0.05% 98
2023
Q3
$221K Sell
2,814
-353
-11% -$29.6K 0.05% 97
2023
Q2
$279K Buy
3,167
+115
+4% +$9.9K 0.07% 85
2023
Q1
$246K Buy
+3,052
New +$249K 0.06% 92

Other funds holding MDT

NBW Capital's MDT Position: Q2 2025 in Review

NBW Capital increased its Medtronic (MDT) stake by 6.4% in Q2 2025, buying an estimated $13K and bringing the position to 2,540 shares worth $221K. The position accounts for 0.05% of the portfolio, ranked #97.

NBW Capital first reported a position in MDT in Q1 2023 and has held it in 8 quarters since. The position peaked at $279K in Q2 2023. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2025.

  • NBW Capital held 2,540 shares of Medtronic worth $221K as of Q2 2025.
  • NBW Capital bought 153 Medtronic shares in Q2 2025, an estimated $13K.
  • Medtronic made up 0.05% of NBW Capital's portfolio in Q2 2025, its #97 holding.
  • NBW Capital first reported a position in Medtronic in Q1 2023 and has held it in 8 quarters since.
  • NBW Capital's Medtronic position peaked at $279K in Q2 2023.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.

Based on NBW Capital's 13F filing for Q2 2025, filed 13 Aug 2025.